一类计算方法,用于在设计第三阶段临床试验时减少选择偏差
1Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois.
Statistics in medicine
|March 5, 2024
概括
由于选择偏差,第三期临床试验可能会高估治疗疗效. 提出了新的计算方法来减少这种估计偏差,并提高治疗效果评估的准确性.
科学领域:
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
- 药学研究 药学研究
背景情况:
- 确认性第三期研究通常基于先前的数据来评估治疗方法.
- 追溯研究表明"在第三阶段治疗效果减弱"的现象.
- 标准估计者可能显著高估了选择治疗组的疗效.
研究的目的:
- 提出计算方法来减少估计偏差和平均平方误差在第3阶段的研究.
- 为了解决在选定的群体中观察到的过高估计治疗疗效的问题.
- 提供适用于多个治疗组和总结数据的灵活框架.
主要方法:
- 开发一类用于减轻估计偏差的计算方法.
- 使用模拟研究来评估方法性能.
- 将方法应用于现实世界的数据示例,以提供实际指导.
主要成果:
- 提出的方法有效地减少了估计偏差和平均平方误差.
- 模拟研究证明了计算方法的实际实用性.
- 该框架显示了各种场景的灵活性,包括多个治疗组.
结论:
- 拟议的计算方法为第三阶段研究中的标准估计器提供了强大的替代方案.
- 这些方法可以提高治疗效果估计的准确性,特别是在选择问题中.
- 该框架提供了实际的实施指导,并作为复杂问题的基础.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.5K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Randomized Experiments
6.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.9K
Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Bias in Epidemiological Studies
265
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
265
